What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Massimo Puoti spends much of his time researching Immunology, Internal medicine, Hepatitis C virus, Hepatitis C and Hepatitis B virus.
His Immunology study integrates concerns from other disciplines, such as Liver disease and Acquired immunodeficiency syndrome.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Sofosbuvir.
The various areas that Massimo Puoti examines in his Hepatitis C virus study include Coinfection, Chronic liver disease, Liver biopsy and Viral load.
His Hepatitis C study combines topics in areas such as Pibrentasvir, Glecaprevir, Transmission, Alpha interferon and Paritaprevir.
His Hepatitis B virus study contributes to a more complete understanding of Virology.
His most cited work include:
- EASL Recommendations on Treatment of Hepatitis C (1837 citations)
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection (1320 citations)
- Statements from the Taormina expert meeting on occult hepatitis B virus infection. (595 citations)
What are the main themes of his work throughout his whole career to date?
Massimo Puoti mainly focuses on Internal medicine, Immunology, Hepatitis C, Hepatitis C virus and Gastroenterology.
His Internal medicine research includes elements of Ribavirin and Viral load.
Viral disease is closely connected to Acquired immunodeficiency syndrome in his research, which is encompassed under the umbrella topic of Immunology.
His Hepatitis C research includes themes of Transmission, Alpha interferon and Intensive care medicine.
His Hepatitis C virus research is multidisciplinary, incorporating elements of Chronic liver disease and Hepatology.
He has included themes like Glecaprevir, Genotype and Ritonavir in his Gastroenterology study.
He most often published in these fields:
- Internal medicine (56.35%)
- Immunology (33.22%)
- Hepatitis C (28.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (56.35%)
- Severe acute respiratory syndrome coronavirus 2 (4.89%)
- Coronavirus disease 2019 (4.89%)
In recent papers he was focusing on the following fields of study:
Massimo Puoti mainly investigates Internal medicine, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Gastroenterology and Hepatitis C.
His Internal medicine study incorporates themes from Pibrentasvir, Hepatitis C virus, Genotype and Glecaprevir.
His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Chronic liver disease, Hepatocellular carcinoma, Hepatology and Hepatitis B virus.
His research in Severe acute respiratory syndrome coronavirus 2 intersects with topics in Liver transplantation, Virology, Young adult, Immunology and Coronavirus.
His Gastroenterology research incorporates themes from Ribavirin, Retrospective cohort study, Kidney disease and Intention-to-treat analysis.
His studies in Hepatitis C integrate themes in fields like Cohort study, Intensive care medicine, Sofosbuvir, Liver disease and Nephritis.
Between 2018 and 2021, his most popular works were:
- Update of the statements on biology and clinical impact of occult hepatitis B virus infection (96 citations)
- EASL recommendations on treatment of hepatitis C: Final update of the series ☆ (66 citations)
- Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Disease
Massimo Puoti focuses on Internal medicine, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Hepatitis C virus and Gastroenterology.
His research integrates issues of Titer, Pibrentasvir and Glecaprevir in his study of Internal medicine.
In his study, Occult, Hbv reactivation, Hepatitis B virus, Ritonavir and Kidney transplantation is strongly linked to Intensive care medicine, which falls under the umbrella field of Coronavirus disease 2019.
His biological study spans a wide range of topics, including Young adult, Serology, Organ transplantation and 2019-20 coronavirus outbreak.
His study explores the link between Hepatitis C virus and topics such as Intention-to-treat analysis that cross with problems in Voxilaprevir, Anemia and Hepatocellular carcinoma.
His Gastroenterology research integrates issues from Ribavirin, Sofosbuvir and Hepatitis C.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
